Achiko Logo cropped.jpg
Achiko Announces the Successful Integration of its Teman Sehat Digital Ecosystem and AptameX Covid-19 Diagnostic Testing Platform for Launch in Indonesia
June 03, 2021 07:30 ET | Achiko AG
Wireless integration of AptameX Covid-19 test with Teman Sehat completedTeman Sehat’s open API allows for integration of third party testing platformsTeman Sehat provides results within 15 minutes,...
Achiko Logo cropped.jpg
Achiko Completes Initial Shipment of AptameX, its Progressive Covid-19 Diagnostic Test to Indonesia, Delivering 77% Sensitivity at Low Viral Loads
May 20, 2021 07:30 ET | Achiko AG
Production of First 1,000 AptameX Test Kits is Concluded in Singapore (initial capacity to test 10,000 patients per day).AptameX Delivers Sensitivity of 77% (95% CI: 75.94 - 79.24) at a High Industry...
Achiko Logo cropped.jpg
Achiko Appoints New Chief Financial Officer and Announces Changes to Senior Team
May 04, 2021 07:30 ET | Achiko AG
Appoints Robert Rieder as Chief Financial OfficerChief Operating Officer Chris Young to Retire Focus on Product Development, Lowering Cost Profile and Improved Alignment of Resources ZURICH,...
Achiko Logo cropped.jpg
Achiko Concludes Phase 1 Study of Project Gumnuts for Covid-19 Testing
January 25, 2021 07:30 ET | Achiko AG
Completion of Phase 1 Testing Demonstrates 91% Sensitivity and 85% SpecificityFurther Optimization Studies are Currently Being Performed and are Expected to Continue to Improve Results and Match WHO...
Achiko Logo cropped.jpg
Achiko AG Enters into a Convertible Note of Up to CHF $2 Million with Negma Group
November 30, 2020 08:30 ET | Achiko AG
ZURICH, Switzerland, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Achiko AG (SWX:ACHI, ISIN CH0522213468) (“the Company”) has entered into a new subordinated convertible loan transaction of up to CHF $2...
Achiko Logo cropped.jpg
Achiko Secures Convertible Loan Facility with Yorkville Advisors of USD $2.5 Million, with a Provisional Extension of Up to USD $9.5 Million
November 26, 2020 07:00 ET | Achiko AG
ZURICH, Switzerland, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Achiko AG (SWX:ACHI, ISIN CH0522213468) announces the completion of a convertible loan facility with US based fund manager Yorkville Advisors...
Achiko Logo cropped.jpg
Achiko AG Appoints Toolbox Medical Innovations and NDA Group and Expands Advisory Board
November 02, 2020 08:52 ET | Achiko AG
Encouraging Initial Results to Date in Field Validation TrialsToolbox Medical Innovations Engaged for the Design of the Commercial Test KitNDA Group Engaged to Assist in Progress Towards CE...
Achiko Logo cropped.jpg
Achiko Establishes MedTech Expert Advisory Board and Expands Management Team
October 13, 2020 12:09 ET | Achiko AG
New international advisory board members: Mr. Glenn Cross (Australia), Dr. Jittaporn Wattanaseree (Thailand) and Ms. Carol Aebi (Switzerland)Management team appointment: Mr. Pierre Nathie of Med2Mark...
Pitt Street Research Issues Updated Report on Achiko AG’s Business Expansion Towards COVID-19 Testing
October 01, 2020 10:29 ET | Achiko AG
SYDNEY, Australia, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Pitt Street Research, based in Sydney, Australia has issued an updated report on Achiko AG (SWX: ACHI) (ACHI.SW) (ISIN: CH0522213468) (the...
Achiko Logo cropped.jpg
Achiko AG Announces Financial Results for Six Months Ended June 30, 2020
September 28, 2020 10:10 ET | Achiko AG
The outbreak of the Covid-19 pandemic towards the end of first quarter 2020 limited Achiko’s ability to execute on its business strategyAchiko responded by developing a Covid-19 testing and ecosystem...